{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:00:15Z","timestamp":1789052415831,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.thromres.2020.09.012","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T02:54:50Z","timestamp":1600224890000},"page":"335-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Validation of the PLASMIC score for predicting ADAMTS13 activity &lt;10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada"],"prefix":"10.1016","volume":"196","author":[{"given":"Chris","family":"Wynick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Britto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arabesque","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Karkhaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Dawn","family":"Goodyear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowei (Linda)","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.09.012_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.thromres.2020.09.012_bb0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature","volume":"45","author":"Amorosi","year":"1966","journal-title":"Medicine"},{"key":"10.1016\/j.thromres.2020.09.012_bb0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.09.012_bb0020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/trf.13359","article-title":"Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura","volume":"56","author":"Connell","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2020.09.012_bb0025","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1055\/s-0039-1696718","article-title":"Evaluation of a new, rapid, fully automated assay for the measurement of ADAMTS13 activity","volume":"119","author":"Valsecchi","year":"2019","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.09.012_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.thromres.2020.09.012_bb0035","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2020.09.012_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/jth.13882","article-title":"External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment","volume":"16","author":"Li","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.09.012_bb0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.transci.2017.06.006","article-title":"Validation of the PLASMIC score at a University Medical Center","volume":"56","author":"Jajosky","year":"2017","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.thromres.2020.09.012_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/vox.12050","article-title":"Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort","volume":"105","author":"Bentley","year":"2013","journal-title":"Vox Sang."},{"key":"10.1016\/j.thromres.2020.09.012_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.09.012_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.thromres.2020.05.045","article-title":"Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: a 10-year provincial retrospective cohort study","volume":"193","author":"Sawler","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.09.012_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2018.10.010","article-title":"Validation of the PLASMIC score, a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis, in Chinese patients","volume":"172","author":"Tang","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.09.012_bb0070","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3109\/14767058.2011.619603","article-title":"A high LDH to AST ratio helps to differentiate pregnancy-associated thrombotic thrombocytopenic purpura (TTP) from HELLP syndrome","volume":"25","author":"Keiser","year":"2012","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"4","key":"10.1016\/j.thromres.2020.09.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS-13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLOS One"},{"key":"10.1016\/j.thromres.2020.09.012_bb0080","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/bjh.15932","article-title":"Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative","volume":"186","author":"Upadhyay","year":"2019","journal-title":"Br. J. Haematol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820305168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820305168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:45:22Z","timestamp":1758735922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820305168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":16,"alternative-id":["S0049384820305168"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.09.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the PLASMIC score for predicting ADAMTS13 activity <10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}